Skip to content
Research Article Open access CC BY 4.0

Practices and Barriers towards Pharmacovigilance and Adverse Drug Reporting among Intern Pharmacists in Nigeria

Shadrach Chinecherem Eze, Evaristus Chinonso Odoh, Kingsley Chinemerem Eze, Wisdom Enyinnaya Arugo, Gerald Obinna Ozota, Ugomma Loveth Anyaji, Collins Chukwuemeka Magbo, Chidimma Elizabeth Mbakamma, Victor Chikaodiri Amaechi, Chimaobi Jude Nwiyi, Kennedy Onyedikachi Ijegalu, Goodness Chizorom Nwokebu

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 27–40 · Published 31 Dec 2022

10.9734/jamps/2022/v24i11587

Abstract

Background: The practice of Pharmacovigilance (PV) and Adverse Drug Reaction (ADR) reporting is very necessary to ensure adequate safety of all drugs in use and is an integral component of post marketing surveillance. Pharmacist, including interns are at a central position in carrying out this important function. Objectives: This study sought to assess the practice of  pharmacovigilance and adverse drug reaction reporting and the perceived barriers towards its implementation among pharmacist interns in Nigeria. Methods: This was a cross-sectional study among pharmacist interns in Nigeria. The 18-item semi-structured questionnaires were administered online using simple random sampling with the snowballing technique to recruit the participants and the results were analyzed with IBM SPSS version 25. Descriptive statistics were used to summarize the data. The chi-square test was used to evaluate associations. Results: A total of 450 pharmacist interns participated in this study. The practice of PV and ADR reporting is poor among the respondents, less than 40% of the participants have ever reported ADR before, while only 29.1% have reported ADR since starting their internship program. Only 35.8% said “yes” to documenting ADR. Verbal information (61.1%) is the most widely used method of reporting ADR. Lack of cohesion among healthcare professionals, unavailability of feedback from relevant authorities, and fear of being wrong are the most reported barriers towards PV and ADR reporting among the participants. This is a correlation between the number of months spent in internship program and the practice of PV by the participants.  ‘Fear of being wrong’ is an essential barrier to PV and ADR reporting among participants in tertiary hospitals (86.0%). Conclusion: The practice of pharmacovigilance is poor among the participants. Many barriers also affect ADR reporting among the interns. Measures should be taken to encourage ADR reporting and the reported barriers should be reviewed to improve pharmacovigilance activities.

Pharmacovigilance adverse drug reaction practice barriers pharmacist interns Nigeria

References (27)

  1. 1 Traditional use and safety of herbal medicines1 [DOI]
  2. 2 Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital [DOI]
  3. 3 Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria [DOI]
  4. 4 COVID-19 and risks to the supply and quality of tests, drugs, and vaccines [DOI]
  5. 5 Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India [DOI]
  6. 6 Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions.
  7. 7 Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria [DOI]
  8. 8 Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting among Healthcare Workers in a Tertiary Centre in Northern Nigeria [DOI]
  9. 9 Calculating the Sample Size in Quantitative Studies [DOI]
  10. 10 Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey [DOI]
  11. 11 Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran [DOI]
  12. 12 Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden [DOI]
  13. 13 Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers [DOI]
  14. 14 Pharmacovigilance of Herbal Medicines [DOI]
  15. 15 Adverse drug reaction reporting in New Zealand: implications for pharmacists.
  16. 16 Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature [DOI]
  17. 17 Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey [DOI]
  18. 18 Pharmacovigilance Perception and Knowledge Among Pharmacists and Interns in Saudi Arabia [DOI]
  19. 19 Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists [DOI]
  20. 20 An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria [DOI]
  21. 21 Knowledge, Attitude, and Practice About Pharmacovigilance Among Healthcare Providers of a Tertiary Care Teaching Hospital in New Delhi (India) [DOI]
  22. 22 Knowledge, Attitude and Practice of Community Pharmacists towards Adverse Drug Reactions Reporting [DOI]
  23. 23 3 Education and Training [DOI]
  24. 24 The need of pharmacovigilance activities in Yemen
  25. 25 An evaluation of knowledge, attitude and perception about adverse drug reactions and pharmacovigilance among intern doctors in a medical college teaching hospital of Sangli [DOI]
  26. 26 Adverse drug reactions reporting culture in Pharmacovigilance Programme of India.
  27. 27 [Adverse drug reactions definitions and terminology].

Cited by 4

Assessing the Impact of the Current Pharmacy Education in the Attitudes of Early Career Pharmacists towards Leadership and Professional Identity in Nigeria

Ifunanya Genevieve Anunwa, Wisdom Enyinnaya Arugo, Samuel Chukwuemeka Okenwa, Chika Augusta Ekweozor, Ozioko Kingsley Chukwuebuka, Lynda Uchechi Iloegbu, Collins Okwudili Nnam, Daniel Ifeanyichukwu Agu, Jane Chidera Nwachukwu · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2025

Pharmacovigilance in Nigeria: Addressing challenges in ensuring drug safety and monitoring adverse effects

Michael Alurame Eruaga, Tabat Bature, E. O. Itua · GSC Advanced Research and Reviews · 2024

Showing 3 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

59

Page views

0

PDF downloads

7

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.